To further explore the relevance of EMID2 in human cancer, we interrogated The Cancer Genome Atlas (TCGA) to analyze the correlation between EMID2 expression levels and survival rates in multiple cohorts of patients diagnosed with aggressive cancer (https://www.nuffieldtrust.org.uk/resource/cancer-survival-rates). This evidence concerns the gene COL26A1 and cancer.